Logo image of AMX.CA

AMEX EXPLORATION INC (AMX.CA) Stock Fundamental Analysis

TSX-V:AMX - TSX Venture Exchange - CA03114B1022 - Common Stock - Currency: CAD

1  -0.02 (-1.96%)

Fundamental Rating

3

Taking everything into account, AMX scores 3 out of 10 in our fundamental rating. AMX was compared to 820 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for AMX as it has an excellent financial health rating, but there are worries on the profitability. AMX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AMX was profitable.
In the past year AMX has reported a negative cash flow from operations.
In multiple years AMX reported negative net income over the last 5 years.
In the past 5 years AMX always reported negative operating cash flow.
AMX.CA Yearly Net Income VS EBIT VS OCF VS FCFAMX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M

1.2 Ratios

The Return On Assets of AMX (0.77%) is better than 85.95% of its industry peers.
AMX has a better Return On Equity (0.94%) than 86.22% of its industry peers.
Industry RankSector Rank
ROA 0.77%
ROE 0.94%
ROIC N/A
ROA(3y)0.26%
ROA(5y)-3.74%
ROE(3y)0.31%
ROE(5y)-4.38%
ROIC(3y)N/A
ROIC(5y)N/A
AMX.CA Yearly ROA, ROE, ROICAMX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMX.CA Yearly Profit, Operating, Gross MarginsAMX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

7

2. Health

2.1 Basic Checks

AMX has about the same amout of shares outstanding than it did 1 year ago.
AMX has more shares outstanding than it did 5 years ago.
AMX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMX.CA Yearly Shares OutstandingAMX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
AMX.CA Yearly Total Debt VS Total AssetsAMX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.76 indicates that AMX is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AMX (2.76) is comparable to the rest of the industry.
There is no outstanding debt for AMX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.76
ROIC/WACCN/A
WACCN/A
AMX.CA Yearly LT Debt VS Equity VS FCFAMX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.51 indicates that AMX has no problem at all paying its short term obligations.
AMX has a Current ratio (2.51) which is comparable to the rest of the industry.
AMX has a Quick Ratio of 2.51. This indicates that AMX is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.51, AMX perfoms like the industry average, outperforming 59.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.51
AMX.CA Yearly Current Assets VS Current LiabilitesAMX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 142.16% over the past year.
EPS 1Y (TTM)142.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AMX will show a very negative growth in Earnings Per Share. The EPS will decrease by -43.93% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-140%
EPS Next 2Y-54.92%
EPS Next 3Y-6.27%
EPS Next 5Y-43.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMX.CA Yearly Revenue VS EstimatesAMX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
AMX.CA Yearly EPS VS EstimatesAMX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 100.00, which means the current valuation is very expensive for AMX.
AMX's Price/Earnings ratio is rather cheap when compared to the industry. AMX is cheaper than 85.95% of the companies in the same industry.
AMX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
The Forward Price/Earnings Ratio is negative for AMX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 100
Fwd PE N/A
AMX.CA Price Earnings VS Forward Price EarningsAMX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMX.CA Per share dataAMX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

AMX's earnings are expected to decrease with -6.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.92%
EPS Next 3Y-6.27%

0

5. Dividend

5.1 Amount

AMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMEX EXPLORATION INC

TSX-V:AMX (2/21/2025, 7:00:00 PM)

1

-0.02 (-1.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-24 2025-03-24/amc
Inst Owners7.29%
Inst Owner ChangeN/A
Ins Owners7.31%
Ins Owner ChangeN/A
Market Cap120.91M
Analysts83.33
Price Target2.42 (142%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5%
PT rev (3m)4.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 100
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)0.01
EY1%
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.9
TBVpS0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 0.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.26%
ROA(5y)-3.74%
ROE(3y)0.31%
ROE(5y)-4.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12179.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.51
Altman-Z 2.76
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)20695.5%
Cap/Depr(5y)31819.5%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.31%
EPS Next Y-140%
EPS Next 2Y-54.92%
EPS Next 3Y-6.27%
EPS Next 5Y-43.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-75%
EBIT Next 3Y-7.72%
EBIT Next 5Y-12.37%
FCF growth 1Y27.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y97.75%
OCF growth 3YN/A
OCF growth 5YN/A